Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Biotech-bay crawled time : 22:01 save search
FDA Approves Amgen's RIABNI™ (rituximab-arrx), A Biosimilar To Rituxan® (rituximab)
Published: 2020-12-17 (Crawled : 22:01) - biospace.com/
AMGN | News | $274.12 0.81% 1.2M
|
Health Technology
|
| O: 0.3%
H: 0.99%
C: 0.93%
fda approval fda approval biosimilar
Model N to Acquire Deloitte’s Life Sciences Pricing and Contracting Solutions Business
Published: 2020-12-17 (Crawled : 22:01) - biospace.com/
MODN | $29.635 0.25% 640K
|
Technology Services
|
| O: 0.81%
H: 1.88%
C: 1.77%
contract life science
Mereo BioPharma and Ultragenyx Announce Collaboration and License Agreement for Setrusumab in Osteogenesis Imperfecta
Published: 2020-12-17 (Crawled : 22:01) - biospace.com/
RARE F | $45.15 3.34% 530K
|
Health Technology
|
| O: 0.73%
H: 3.04%
C: 1.56%
MREO | $2.8 0.36% 560K
|
Health Technology
|
| O: 2.78%
H: 1.8%
C: -0.45%
biopharma license collaboration announces collaboration
Ultragenyx and Mereo BioPharma Announce Collaboration and License Agreement for Setrusumab in Osteogenesis Imperfecta
Published: 2020-12-17 (Crawled : 22:01) - biospace.com/
RARE F | $45.15 3.34% 530K
|
Health Technology
|
| O: 0.73%
H: 3.04%
C: 1.56%
MREO | $2.8 0.36% 560K
|
Health Technology
|
| O: 2.78%
H: 1.8%
C: -0.45%
biopharma license collaboration announces collaboration
Gainers vs Losers
| 86% | 14% |
Top 10 Gainers
MTTR | News M | $4.56 162.07% 21M
|
AGBA | $2.74 119.2% 52M
|
Finance
CZOO | $9.07 81.76% 22M
|
EDBL | News | $6.56 74.47% 1.8M
|
MTC | $2.21 41.67% 5.6M
|
Technology Services
OPRT | News | $3.12 38.67% 11M
|
Finance
PALI | $6.59 33.67% 23M
|
Manufacturing
VNRX | $0.7989 33.15% 3.2M
|
Health Technology
BTCM | $3.51 30.0% 730K
|
Arts, Entertainment, and Recrea...
MLEC | $1.81 29.29% 2.8M
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.